Who Paid My Doc
Jennifer Whitaker
Infectious Disease Houston, TX
NPI 1316124746 CMS profile 514230
1504 Taub Loop, Houston, TX 77030
General payments
$0
Research payments
$0
Ownership & investment interest
$0
The CMS Open Payments record contains no reported payments to Jennifer Whitaker of Houston, TX.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
Prescribing to Medicare patients
Part D · data year 2024 · 24 drugsPart D claims
568
Drug cost
$743,101
Branded share of claims
48.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | Brand | 111 | $415,216 | |
| Tivicay Dolutegravir Sodium | Brand | 47 | $96,008 | |
| Descovy Emtricitabine/Tenofov Alafenam | Brand | 29 | $65,014 | |
| Stribild Elviteg/Cob/Emtri/Tenofo Disop | Brand | 12 | $57,137 | |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | Brand | 15 | $55,461 | |
| Darunavir | Generic | 25 | $17,174 | |
| Atovaquone | Generic | 11 | $14,424 | |
| Edurant Rilpivirine Hcl | Brand | 12 | $12,282 | |
| Linzess Linaclotide | Brand | 14 | $6,927 | |
| Ritonavir | Generic | 23 | $1,247 |
The 10 drugs with the highest cost, of 24 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,546 Part D prescribers listed as Infectious Disease; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 6 billing codesPaid by Medicare
$1,940
Medicare patients
12
Services billed
32
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Atrial fibrillation | 0% | |
| Osteoporosis | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Related records
Infectious Disease in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Infectious Disease
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.